WuXi AppTec Passes FDA Inspection
News Apr 14, 2016
WuXi AppTec has announced that WuXi Lab Testing Division (LTD)’s late-and commercial-stage analytical and stability testing facilities in Shanghai successfully passed an FDA inspection for GMP compliance.
The inspector from FDA China office evaluated WuXi LTD’s quality system during a 4-day inspection, with focus on data integrity and compliance across its GMP analytical and stability testing facilities.
The inspection outcome confirmed WuXi’s adherence to FDA’s rigorous GMP guidance and its high quality of operation.
“FDA expects the highest quality and data integrity, and we are proud to receive a very positive feedback, ”said Dr. Ge Li, Chairman and CEO of WuXi AppTec, “ We will continue to uphold the highest quality standards and provide best-in-class R&D services for our customers worldwide.”
8th Edition of International Conference and Exhibition on Separation Techniques
Jul 29 - Jul 30, 2019
International Women Health and Breast Cancer Conference
Jul 03 - Jul 05, 2019
2nd International Conference on Biological & Pharmaceutical Sciences
Jul 12 - Jul 13, 2019
2nd International Conference on Computational Biology and Bioinformatics
May 17 - May 18, 2019